Cardiometabolic profile of people screened for high risk of type 2 diabetes in a national diabetes prevention programme (FIN-D2D)

被引:26
作者
Saaristo, Timo [1 ,2 ]
Moilanen, Leena [3 ]
Jokelainen, Jari [4 ]
Korpi-Hyovalti, Eeva [5 ]
Vanhala, Mauno [6 ]
Saltevo, Juha [8 ]
Niskanen, Leo [3 ]
Peltonen, Markku [9 ]
Oksa, Heikki [2 ]
Cederberg, Henna [4 ]
Tuomilehto, Jaakko [10 ]
Uusitupa, Matti [7 ]
Keinanen-Kiukaanniemi, Sirkka [4 ,11 ,12 ]
机构
[1] Finnish Diabet Assoc, Tampere 33680, Finland
[2] Pirkanmaa Hosp Dist, Tampere, Finland
[3] Kuopio Univ Hosp, Dept Med, No Savo Hosp Dist, SF-70210 Kuopio, Finland
[4] Univ Oulu, Inst Hlth Sci, Oulu, Finland
[5] Seinajoki Cent Hosp, Dept Internal Med, Seinajoki, Finland
[6] Cent Finland Cent Hosp, Unit Family Practice, Jyvaskyla, Finland
[7] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland
[8] Cent Finland Hosp Dist, Dept Internal Med, Jyvaskyla, Finland
[9] Natl Inst Hlth & Welf, Helsinki, Finland
[10] Univ Helsinki, Helsinki, Finland
[11] N Ostrobothnia Hosp Dist, Oulu, Finland
[12] Hlth Ctr Oulu, Oulu, Finland
基金
芬兰科学院;
关键词
FINDRISC; High-risk strategy; Screening; Metabolic syndrome; Type; 2; diabetes; Impaired fasting glucose; Impaired glucose tolerance; Cardiovascular disease; Framingham risk engine; SCORE; Primary health care; LIFE-STYLE INTERVENTION; IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; HIGH PREVALENCE; REAL-WORLD; MORTALITY; COMMUNITY; HEART; IMPLEMENTATION;
D O I
10.1016/j.pcd.2010.05.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To study screening of high-risk individuals as part of a national diabetes prevention programme in primary health care settings in Finland between 2003 and 2007, and evaluate the cardiometabolic risk profile of persons identified for intervention. Methods: High-risk individuals were identified by the Finnish Diabetes Risk Score (FINDRISC), history of impaired fasting glucose (IFG), impaired glucose tolerance (IGT), cardiovascular disease (CVD), or gestational diabetes. Participants subsequently underwent an oral glucose tolerance test. CVD morbidity risk was estimated by the Framingham Study Risk Equation and CVD mortality risk by the Systematic Coronary Risk Evaluation Formula (SCORE). Results: A high-risk cohort of 10,149 (of whom 30.3% men) was identified (mean age 54.7 for men, 53.0 for women). Altogether 18.8% of men and 11.5% of women had screen-detected diabetes. In total 68.1% of men and 49.4% of women had abnormal glucose tolerance (IFG, IGT or screen-detected diabetes). Furthermore, 43.2% and 41.5% of men, and 13.3% and 11.3% of women, respectively, had a high predicted risk of CVD morbidity or mortality. Conclusion: Prevalence of dysglycemia including undiagnosed diabetes and the predicted risk for CVD was alarmly high in the identified high-risk cohort, particularly in men. (C) 2010 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:231 / 239
页数:9
相关论文
共 43 条
[21]  
2-T
[22]   Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S [J].
Gregg, EW ;
Cadwell, BL ;
Cheng, YJ ;
Cowie, CC ;
Williams, DE ;
Geiss, L ;
Engelgau, MM ;
Vinicor, F .
DIABETES CARE, 2004, 27 (12) :2806-2812
[23]   Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [J].
Grundy, SM ;
Cleeman, JI ;
Daniels, SR ;
Donato, KA ;
Eckel, RH ;
Franklin, BA ;
Gordon, DJ ;
Krauss, RM ;
Savage, PJ ;
Smith, SC ;
Spertus, JA ;
Costa, F .
CIRCULATION, 2005, 112 (17) :2735-2752
[24]   The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease [J].
Hu, G ;
Jousilahti, P ;
Qiao, Q ;
Peltonen, M ;
Katoh, S ;
Tuomilehto, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (09) :1413-1418
[25]   Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction [J].
Hu, G ;
Jousilahti, P ;
Qiao, Q ;
Katoh, S ;
Tuomilehto, J .
DIABETOLOGIA, 2005, 48 (05) :856-861
[26]  
Knowler William C, 2002, N Engl J Med, V346, P393, DOI 10.1056/NEJMoa012512
[27]   Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males [J].
Kosaka, K ;
Noda, M ;
Kuzuya, T .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 67 (02) :152-162
[28]   EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries [J].
Kotseva, Kornelia ;
Wood, David ;
De Backer, Guy ;
De Bacquer, Dirk ;
Pyorala, Kalevi ;
Keil, Ulrich .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2009, 16 (02) :121-137
[29]   The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study [J].
Li, Guangwei ;
Zhang, Ping ;
Wang, Jinping ;
Gregg, Edward W. ;
Yang, Wenying ;
Gong, Qiuhong ;
Li, Hui ;
Li, Hongliang ;
Jiang, Yayun ;
An, Yali ;
Shuai, Ying ;
Zhang, Bo ;
Zhang, Jingling ;
Thompson, Theodore J. ;
Gerzoff, Robert B. ;
Roglic, Gojka ;
Hu, Yinghua ;
Bennett, Peter H. .
LANCET, 2008, 371 (9626) :1783-1789
[30]   The diabetes risk score -: A practical tool to predict type 2 diabetes risk [J].
Lindström, J ;
Tuomilehto, J .
DIABETES CARE, 2003, 26 (03) :725-731